Comparison of the expression of specific cell surface epitopes on in vitro fertilized and parthenogenetic bovine embryos.
Parthenogenetic embryos, which are produced by the spontaneous or artificial stimulation of the oocyte, partially develop in the complete absence of the male gamete but fail to produce live young in many mammalian species. The identification of developmentally regulated molecules on the cell surface of embryos has implicated their possible role in cell interactions during embryogenesis and differentiation. In this study the expression patterns of four stage-specific cell surface antigenic determinants (TEC-1, -2, -3, and -4) were investigated in both parthenogenetic and in vitro fertilized bovine embryos. When compared to embryos produced using in vitro fertilization methods the parthenogenotes, although appearing morphologically normal, differed markedly in their TEC epitope pattern of presentation. TEC-1, -2, -3, and -4 epitope presentation on in vitro fertilized embryos occurred during specific stages of preimplantation development. TEC-1 and -2 presentation was detected on oocytes and blastocysts only, TEC-3 on morulae and blastocysts, and TEC-4 on oocytes through to 8-cell embryos, with all subsequent stages negative. Parthenogenetic embryos did not show TEC-1, -2, or -3 epitope presentation whereas the TEC-4 epitope was present throughout the developmental period examined. Enzymatic cleavage of sialic acid residues on in vitro fertilized and parthenogenetic embryos resulted in presentation of the TEC epitopes during all the embryonic stages. Western blot analysis of the embryos showed the TEC epitopes to be present on all the embryonic stages examined. This study suggests the mechanisms responsible for control and presentation of each of the TEC epitopes may not be functioning the same in parthenogenetic embryos that undergo changed glycosylation or deglycosylation resulting in altered patterns of sialylation. The study also shows TEC epitope presentation may prove to be a useful indicator of parthenogenetically activated bovine embryos. J. Exp. Zool. 284:392-400, 1999.
Gougoulidis
T
T
Centre for Early Human Development, Institute of Reproduction and Development, Monash University, Monash Medical Centre, Clayton, Victoria 3168, Australia.
Trounson
A O
AO
Draber
P
P
Dowsing
A T
AT
D000818:Animals; D000954:Antigens, Surface / Q000378:metabolism; D015153:Blotting, Western; D002417:Cattle; D004268:DNA-Binding Proteins / Q000378:metabolism*; D004622:Embryo, Mammalian / Q000166:cytology / Q000378:metabolism*; D005314:Embryonic and Fetal Development / Q000502:physiology; D000939:Epitopes / Q000378:metabolism*; D005260:Female; D005307:Fertilization in Vitro; D019084:Fluorescent Antibody Technique, Indirect; D008297:Male; D009687:Nuclear Proteins / Q000378:metabolism*; D009865:Oocytes / Q000166:cytology / Q000378:metabolism; D010312:Parthenogenesis / Q000502:physiology*
D000954:Antigens, Surface; D004268:DNA-Binding Proteins; D000939:Epitopes; D009687:Nuclear Proteins